nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—CYP1A2—Dacarbazine—muscle cancer	0.0873	0.139	CbGbCtD
Fluoxetine—ABCB1—Dactinomycin—muscle cancer	0.0662	0.105	CbGbCtD
Fluoxetine—CYP3A5—Vincristine—muscle cancer	0.0626	0.0998	CbGbCtD
Fluoxetine—CYP3A5—Etoposide—muscle cancer	0.0574	0.0915	CbGbCtD
Fluoxetine—CYP2B6—Doxorubicin—muscle cancer	0.0497	0.0792	CbGbCtD
Fluoxetine—ALB—Methotrexate—muscle cancer	0.0472	0.0752	CbGbCtD
Fluoxetine—CYP1A2—Etoposide—muscle cancer	0.0427	0.0681	CbGbCtD
Fluoxetine—ABCB1—Vincristine—muscle cancer	0.0407	0.065	CbGbCtD
Fluoxetine—ABCB1—Etoposide—muscle cancer	0.0373	0.0595	CbGbCtD
Fluoxetine—ABCB1—Doxorubicin—muscle cancer	0.0255	0.0406	CbGbCtD
Fluoxetine—ABCB1—Methotrexate—muscle cancer	0.0247	0.0393	CbGbCtD
Fluoxetine—CYP3A4—Vincristine—muscle cancer	0.0244	0.0389	CbGbCtD
Fluoxetine—CYP2D6—Doxorubicin—muscle cancer	0.024	0.0383	CbGbCtD
Fluoxetine—CYP3A4—Etoposide—muscle cancer	0.0224	0.0357	CbGbCtD
Fluoxetine—CYP3A4—Doxorubicin—muscle cancer	0.0153	0.0243	CbGbCtD
Fluoxetine—Chest pain—Etoposide—muscle cancer	0.000335	0.0009	CcSEcCtD
Fluoxetine—Eosinophilia—Methotrexate—muscle cancer	0.000335	0.000899	CcSEcCtD
Fluoxetine—Affect lability—Doxorubicin—muscle cancer	0.000334	0.000896	CcSEcCtD
Fluoxetine—Migraine—Doxorubicin—muscle cancer	0.000334	0.000896	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000333	0.000893	CcSEcCtD
Fluoxetine—Pancreatitis—Methotrexate—muscle cancer	0.000332	0.000891	CcSEcCtD
Fluoxetine—Discomfort—Etoposide—muscle cancer	0.000331	0.000889	CcSEcCtD
Fluoxetine—Face oedema—Doxorubicin—muscle cancer	0.000328	0.000879	CcSEcCtD
Fluoxetine—Hypersensitivity—Dactinomycin—muscle cancer	0.000327	0.000878	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Vincristine—muscle cancer	0.000325	0.00087	CcSEcCtD
Fluoxetine—Confusional state—Etoposide—muscle cancer	0.000324	0.00087	CcSEcCtD
Fluoxetine—Cardiac arrest—Doxorubicin—muscle cancer	0.000323	0.000865	CcSEcCtD
Fluoxetine—Pancytopenia—Methotrexate—muscle cancer	0.000322	0.000863	CcSEcCtD
Fluoxetine—Anaphylactic shock—Etoposide—muscle cancer	0.000322	0.000862	CcSEcCtD
Fluoxetine—Mood swings—Doxorubicin—muscle cancer	0.000321	0.000862	CcSEcCtD
Fluoxetine—Infection—Etoposide—muscle cancer	0.000319	0.000857	CcSEcCtD
Fluoxetine—Ataxia—Doxorubicin—muscle cancer	0.000319	0.000856	CcSEcCtD
Fluoxetine—Asthenia—Dactinomycin—muscle cancer	0.000319	0.000855	CcSEcCtD
Fluoxetine—Dysuria—Methotrexate—muscle cancer	0.000317	0.000849	CcSEcCtD
Fluoxetine—Dehydration—Doxorubicin—muscle cancer	0.000316	0.000846	CcSEcCtD
Fluoxetine—Thrombocytopenia—Etoposide—muscle cancer	0.000315	0.000844	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000315	0.000844	CcSEcCtD
Fluoxetine—Tachycardia—Etoposide—muscle cancer	0.000314	0.000842	CcSEcCtD
Fluoxetine—Abdominal pain—Vincristine—muscle cancer	0.000314	0.000842	CcSEcCtD
Fluoxetine—Body temperature increased—Vincristine—muscle cancer	0.000314	0.000842	CcSEcCtD
Fluoxetine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000313	0.00084	CcSEcCtD
Fluoxetine—Skin disorder—Etoposide—muscle cancer	0.000312	0.000838	CcSEcCtD
Fluoxetine—Erectile dysfunction—Methotrexate—muscle cancer	0.000312	0.000837	CcSEcCtD
Fluoxetine—Dry skin—Doxorubicin—muscle cancer	0.000311	0.000834	CcSEcCtD
Fluoxetine—Hyperhidrosis—Etoposide—muscle cancer	0.000311	0.000834	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00031	0.000831	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000309	0.000829	CcSEcCtD
Fluoxetine—Hypokalaemia—Doxorubicin—muscle cancer	0.000309	0.000828	CcSEcCtD
Fluoxetine—Breast disorder—Doxorubicin—muscle cancer	0.000307	0.000822	CcSEcCtD
Fluoxetine—Anorexia—Etoposide—muscle cancer	0.000306	0.000822	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000306	0.000819	CcSEcCtD
Fluoxetine—Diarrhoea—Dactinomycin—muscle cancer	0.000304	0.000815	CcSEcCtD
Fluoxetine—Pneumonia—Methotrexate—muscle cancer	0.000304	0.000815	CcSEcCtD
Fluoxetine—Drowsiness—Methotrexate—muscle cancer	0.000302	0.00081	CcSEcCtD
Fluoxetine—Depression—Methotrexate—muscle cancer	0.000301	0.000808	CcSEcCtD
Fluoxetine—Hypotension—Etoposide—muscle cancer	0.0003	0.000806	CcSEcCtD
Fluoxetine—Gastritis—Doxorubicin—muscle cancer	0.0003	0.000805	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000299	0.000803	CcSEcCtD
Fluoxetine—Muscular weakness—Doxorubicin—muscle cancer	0.000299	0.000803	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000299	0.000803	CcSEcCtD
Fluoxetine—Renal failure—Methotrexate—muscle cancer	0.000297	0.000796	CcSEcCtD
Fluoxetine—Abdominal distension—Doxorubicin—muscle cancer	0.000295	0.000792	CcSEcCtD
Fluoxetine—Stomatitis—Methotrexate—muscle cancer	0.000294	0.000789	CcSEcCtD
Fluoxetine—Conjunctivitis—Methotrexate—muscle cancer	0.000294	0.000787	CcSEcCtD
Fluoxetine—Dysphagia—Doxorubicin—muscle cancer	0.000293	0.000787	CcSEcCtD
Fluoxetine—Influenza—Doxorubicin—muscle cancer	0.000293	0.000787	CcSEcCtD
Fluoxetine—Asthma—Doxorubicin—muscle cancer	0.000293	0.000787	CcSEcCtD
Fluoxetine—Hypersensitivity—Vincristine—muscle cancer	0.000292	0.000784	CcSEcCtD
Fluoxetine—Eosinophilia—Doxorubicin—muscle cancer	0.00029	0.000779	CcSEcCtD
Fluoxetine—Sweating—Methotrexate—muscle cancer	0.000289	0.000776	CcSEcCtD
Fluoxetine—Paraesthesia—Etoposide—muscle cancer	0.000289	0.000774	CcSEcCtD
Fluoxetine—Haematuria—Methotrexate—muscle cancer	0.000288	0.000772	CcSEcCtD
Fluoxetine—Pancreatitis—Doxorubicin—muscle cancer	0.000288	0.000771	CcSEcCtD
Fluoxetine—Dyspnoea—Etoposide—muscle cancer	0.000287	0.000769	CcSEcCtD
Fluoxetine—Somnolence—Etoposide—muscle cancer	0.000286	0.000767	CcSEcCtD
Fluoxetine—Angina pectoris—Doxorubicin—muscle cancer	0.000286	0.000766	CcSEcCtD
Fluoxetine—Epistaxis—Methotrexate—muscle cancer	0.000285	0.000764	CcSEcCtD
Fluoxetine—Asthenia—Vincristine—muscle cancer	0.000285	0.000764	CcSEcCtD
Fluoxetine—Vomiting—Dactinomycin—muscle cancer	0.000282	0.000758	CcSEcCtD
Fluoxetine—Bronchitis—Doxorubicin—muscle cancer	0.000282	0.000756	CcSEcCtD
Fluoxetine—Rash—Dactinomycin—muscle cancer	0.00028	0.000751	CcSEcCtD
Fluoxetine—Decreased appetite—Etoposide—muscle cancer	0.000279	0.00075	CcSEcCtD
Fluoxetine—Pancytopenia—Doxorubicin—muscle cancer	0.000278	0.000747	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000278	0.000744	CcSEcCtD
Fluoxetine—Fatigue—Etoposide—muscle cancer	0.000277	0.000743	CcSEcCtD
Fluoxetine—Constipation—Etoposide—muscle cancer	0.000275	0.000737	CcSEcCtD
Fluoxetine—Pain—Etoposide—muscle cancer	0.000275	0.000737	CcSEcCtD
Fluoxetine—Dysuria—Doxorubicin—muscle cancer	0.000274	0.000735	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000273	0.000731	CcSEcCtD
Fluoxetine—Haemoglobin—Methotrexate—muscle cancer	0.000272	0.000731	CcSEcCtD
Fluoxetine—Diarrhoea—Vincristine—muscle cancer	0.000272	0.000728	CcSEcCtD
Fluoxetine—Haemorrhage—Methotrexate—muscle cancer	0.000271	0.000727	CcSEcCtD
Fluoxetine—Hepatitis—Methotrexate—muscle cancer	0.000271	0.000727	CcSEcCtD
Fluoxetine—Pollakiuria—Doxorubicin—muscle cancer	0.000271	0.000727	CcSEcCtD
Fluoxetine—Pharyngitis—Methotrexate—muscle cancer	0.000269	0.000722	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000268	0.000718	CcSEcCtD
Fluoxetine—Weight increased—Doxorubicin—muscle cancer	0.000267	0.000716	CcSEcCtD
Fluoxetine—Weight decreased—Doxorubicin—muscle cancer	0.000265	0.000712	CcSEcCtD
Fluoxetine—Feeling abnormal—Etoposide—muscle cancer	0.000265	0.000711	CcSEcCtD
Fluoxetine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000265	0.000709	CcSEcCtD
Fluoxetine—Nausea—Dactinomycin—muscle cancer	0.000264	0.000708	CcSEcCtD
Fluoxetine—Pneumonia—Doxorubicin—muscle cancer	0.000263	0.000705	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Etoposide—muscle cancer	0.000263	0.000705	CcSEcCtD
Fluoxetine—Dizziness—Vincristine—muscle cancer	0.000262	0.000704	CcSEcCtD
Fluoxetine—Drowsiness—Doxorubicin—muscle cancer	0.000261	0.000701	CcSEcCtD
Fluoxetine—Visual impairment—Methotrexate—muscle cancer	0.000261	0.000701	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000259	0.000695	CcSEcCtD
Fluoxetine—Renal failure—Doxorubicin—muscle cancer	0.000257	0.000689	CcSEcCtD
Fluoxetine—Erythema multiforme—Methotrexate—muscle cancer	0.000256	0.000687	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000256	0.000687	CcSEcCtD
Fluoxetine—Urticaria—Etoposide—muscle cancer	0.000255	0.000685	CcSEcCtD
Fluoxetine—Stomatitis—Doxorubicin—muscle cancer	0.000255	0.000684	CcSEcCtD
Fluoxetine—Jaundice—Doxorubicin—muscle cancer	0.000255	0.000684	CcSEcCtD
Fluoxetine—Body temperature increased—Etoposide—muscle cancer	0.000254	0.000682	CcSEcCtD
Fluoxetine—Abdominal pain—Etoposide—muscle cancer	0.000254	0.000682	CcSEcCtD
Fluoxetine—Urinary tract infection—Doxorubicin—muscle cancer	0.000254	0.000682	CcSEcCtD
Fluoxetine—Conjunctivitis—Doxorubicin—muscle cancer	0.000254	0.000682	CcSEcCtD
Fluoxetine—Tinnitus—Methotrexate—muscle cancer	0.000253	0.000678	CcSEcCtD
Fluoxetine—Vomiting—Vincristine—muscle cancer	0.000252	0.000677	CcSEcCtD
Fluoxetine—Sweating—Doxorubicin—muscle cancer	0.000251	0.000672	CcSEcCtD
Fluoxetine—Rash—Vincristine—muscle cancer	0.00025	0.000671	CcSEcCtD
Fluoxetine—Dermatitis—Vincristine—muscle cancer	0.00025	0.000671	CcSEcCtD
Fluoxetine—Haematuria—Doxorubicin—muscle cancer	0.000249	0.000669	CcSEcCtD
Fluoxetine—Headache—Vincristine—muscle cancer	0.000249	0.000667	CcSEcCtD
Fluoxetine—Epistaxis—Doxorubicin—muscle cancer	0.000247	0.000661	CcSEcCtD
Fluoxetine—Sinusitis—Doxorubicin—muscle cancer	0.000245	0.000658	CcSEcCtD
Fluoxetine—Chills—Methotrexate—muscle cancer	0.000243	0.000652	CcSEcCtD
Fluoxetine—Alopecia—Methotrexate—muscle cancer	0.00024	0.000642	CcSEcCtD
Fluoxetine—Bradycardia—Doxorubicin—muscle cancer	0.000239	0.000641	CcSEcCtD
Fluoxetine—Mental disorder—Methotrexate—muscle cancer	0.000237	0.000637	CcSEcCtD
Fluoxetine—Hypersensitivity—Etoposide—muscle cancer	0.000237	0.000635	CcSEcCtD
Fluoxetine—Malnutrition—Methotrexate—muscle cancer	0.000236	0.000633	CcSEcCtD
Fluoxetine—Haemoglobin—Doxorubicin—muscle cancer	0.000236	0.000633	CcSEcCtD
Fluoxetine—Nausea—Vincristine—muscle cancer	0.000236	0.000632	CcSEcCtD
Fluoxetine—Rhinitis—Doxorubicin—muscle cancer	0.000235	0.000631	CcSEcCtD
Fluoxetine—Haemorrhage—Doxorubicin—muscle cancer	0.000235	0.00063	CcSEcCtD
Fluoxetine—Hepatitis—Doxorubicin—muscle cancer	0.000235	0.00063	CcSEcCtD
Fluoxetine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000234	0.000626	CcSEcCtD
Fluoxetine—Pharyngitis—Doxorubicin—muscle cancer	0.000233	0.000625	CcSEcCtD
Fluoxetine—Oedema peripheral—Doxorubicin—muscle cancer	0.000231	0.00062	CcSEcCtD
Fluoxetine—Dysgeusia—Methotrexate—muscle cancer	0.000231	0.00062	CcSEcCtD
Fluoxetine—Asthenia—Etoposide—muscle cancer	0.000231	0.000619	CcSEcCtD
Fluoxetine—Back pain—Methotrexate—muscle cancer	0.000228	0.000612	CcSEcCtD
Fluoxetine—Pruritus—Etoposide—muscle cancer	0.000227	0.00061	CcSEcCtD
Fluoxetine—Visual impairment—Doxorubicin—muscle cancer	0.000226	0.000607	CcSEcCtD
Fluoxetine—Erythema multiforme—Doxorubicin—muscle cancer	0.000222	0.000595	CcSEcCtD
Fluoxetine—Diarrhoea—Etoposide—muscle cancer	0.00022	0.00059	CcSEcCtD
Fluoxetine—Ill-defined disorder—Methotrexate—muscle cancer	0.000219	0.000587	CcSEcCtD
Fluoxetine—Tinnitus—Doxorubicin—muscle cancer	0.000219	0.000587	CcSEcCtD
Fluoxetine—Anaemia—Methotrexate—muscle cancer	0.000218	0.000585	CcSEcCtD
Fluoxetine—Malaise—Methotrexate—muscle cancer	0.000213	0.000571	CcSEcCtD
Fluoxetine—Dizziness—Etoposide—muscle cancer	0.000213	0.00057	CcSEcCtD
Fluoxetine—Vertigo—Methotrexate—muscle cancer	0.000212	0.000569	CcSEcCtD
Fluoxetine—Leukopenia—Methotrexate—muscle cancer	0.000211	0.000567	CcSEcCtD
Fluoxetine—Chills—Doxorubicin—muscle cancer	0.000211	0.000565	CcSEcCtD
Fluoxetine—Arrhythmia—Doxorubicin—muscle cancer	0.00021	0.000562	CcSEcCtD
Fluoxetine—Alopecia—Doxorubicin—muscle cancer	0.000207	0.000556	CcSEcCtD
Fluoxetine—Cough—Methotrexate—muscle cancer	0.000206	0.000552	CcSEcCtD
Fluoxetine—Mental disorder—Doxorubicin—muscle cancer	0.000206	0.000552	CcSEcCtD
Fluoxetine—Convulsion—Methotrexate—muscle cancer	0.000204	0.000548	CcSEcCtD
Fluoxetine—Vomiting—Etoposide—muscle cancer	0.000204	0.000548	CcSEcCtD
Fluoxetine—Malnutrition—Doxorubicin—muscle cancer	0.000204	0.000548	CcSEcCtD
Fluoxetine—Rash—Etoposide—muscle cancer	0.000203	0.000544	CcSEcCtD
Fluoxetine—Dermatitis—Etoposide—muscle cancer	0.000203	0.000543	CcSEcCtD
Fluoxetine—Headache—Etoposide—muscle cancer	0.000201	0.00054	CcSEcCtD
Fluoxetine—Flatulence—Doxorubicin—muscle cancer	0.000201	0.00054	CcSEcCtD
Fluoxetine—Arthralgia—Methotrexate—muscle cancer	0.000201	0.000539	CcSEcCtD
Fluoxetine—Chest pain—Methotrexate—muscle cancer	0.000201	0.000539	CcSEcCtD
Fluoxetine—Myalgia—Methotrexate—muscle cancer	0.000201	0.000539	CcSEcCtD
Fluoxetine—Tension—Doxorubicin—muscle cancer	0.000201	0.000538	CcSEcCtD
Fluoxetine—Dysgeusia—Doxorubicin—muscle cancer	0.0002	0.000537	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0002	0.000535	CcSEcCtD
Fluoxetine—Discomfort—Methotrexate—muscle cancer	0.000198	0.000532	CcSEcCtD
Fluoxetine—Nervousness—Doxorubicin—muscle cancer	0.000198	0.000532	CcSEcCtD
Fluoxetine—Back pain—Doxorubicin—muscle cancer	0.000198	0.00053	CcSEcCtD
Fluoxetine—Muscle spasms—Doxorubicin—muscle cancer	0.000196	0.000527	CcSEcCtD
Fluoxetine—Confusional state—Methotrexate—muscle cancer	0.000194	0.000521	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methotrexate—muscle cancer	0.000193	0.000517	CcSEcCtD
Fluoxetine—Infection—Methotrexate—muscle cancer	0.000191	0.000513	CcSEcCtD
Fluoxetine—Nausea—Etoposide—muscle cancer	0.000191	0.000512	CcSEcCtD
Fluoxetine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00019	0.000508	CcSEcCtD
Fluoxetine—Anaemia—Doxorubicin—muscle cancer	0.000189	0.000507	CcSEcCtD
Fluoxetine—Thrombocytopenia—Methotrexate—muscle cancer	0.000189	0.000506	CcSEcCtD
Fluoxetine—Agitation—Doxorubicin—muscle cancer	0.000188	0.000504	CcSEcCtD
Fluoxetine—Skin disorder—Methotrexate—muscle cancer	0.000187	0.000502	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methotrexate—muscle cancer	0.000186	0.000499	CcSEcCtD
Fluoxetine—Malaise—Doxorubicin—muscle cancer	0.000184	0.000494	CcSEcCtD
Fluoxetine—Vertigo—Doxorubicin—muscle cancer	0.000184	0.000492	CcSEcCtD
Fluoxetine—Anorexia—Methotrexate—muscle cancer	0.000184	0.000492	CcSEcCtD
Fluoxetine—Syncope—Doxorubicin—muscle cancer	0.000183	0.000491	CcSEcCtD
Fluoxetine—Leukopenia—Doxorubicin—muscle cancer	0.000183	0.000491	CcSEcCtD
Fluoxetine—Palpitations—Doxorubicin—muscle cancer	0.000181	0.000484	CcSEcCtD
Fluoxetine—Hypotension—Methotrexate—muscle cancer	0.00018	0.000483	CcSEcCtD
Fluoxetine—Loss of consciousness—Doxorubicin—muscle cancer	0.00018	0.000482	CcSEcCtD
Fluoxetine—Cough—Doxorubicin—muscle cancer	0.000178	0.000478	CcSEcCtD
Fluoxetine—Convulsion—Doxorubicin—muscle cancer	0.000177	0.000475	CcSEcCtD
Fluoxetine—Hypertension—Doxorubicin—muscle cancer	0.000176	0.000473	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000175	0.000471	CcSEcCtD
Fluoxetine—Insomnia—Methotrexate—muscle cancer	0.000174	0.000467	CcSEcCtD
Fluoxetine—Chest pain—Doxorubicin—muscle cancer	0.000174	0.000467	CcSEcCtD
Fluoxetine—Arthralgia—Doxorubicin—muscle cancer	0.000174	0.000467	CcSEcCtD
Fluoxetine—Myalgia—Doxorubicin—muscle cancer	0.000174	0.000467	CcSEcCtD
Fluoxetine—Anxiety—Doxorubicin—muscle cancer	0.000173	0.000465	CcSEcCtD
Fluoxetine—Paraesthesia—Methotrexate—muscle cancer	0.000173	0.000464	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000173	0.000463	CcSEcCtD
Fluoxetine—Discomfort—Doxorubicin—muscle cancer	0.000172	0.000461	CcSEcCtD
Fluoxetine—Dyspnoea—Methotrexate—muscle cancer	0.000172	0.000461	CcSEcCtD
Fluoxetine—Somnolence—Methotrexate—muscle cancer	0.000171	0.000459	CcSEcCtD
Fluoxetine—Dry mouth—Doxorubicin—muscle cancer	0.00017	0.000456	CcSEcCtD
Fluoxetine—Dyspepsia—Methotrexate—muscle cancer	0.00017	0.000455	CcSEcCtD
Fluoxetine—Confusional state—Doxorubicin—muscle cancer	0.000168	0.000451	CcSEcCtD
Fluoxetine—Decreased appetite—Methotrexate—muscle cancer	0.000167	0.000449	CcSEcCtD
Fluoxetine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000167	0.000447	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000166	0.000446	CcSEcCtD
Fluoxetine—Fatigue—Methotrexate—muscle cancer	0.000166	0.000445	CcSEcCtD
Fluoxetine—Infection—Doxorubicin—muscle cancer	0.000166	0.000444	CcSEcCtD
Fluoxetine—Pain—Methotrexate—muscle cancer	0.000165	0.000442	CcSEcCtD
Fluoxetine—Shock—Doxorubicin—muscle cancer	0.000164	0.00044	CcSEcCtD
Fluoxetine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000163	0.000438	CcSEcCtD
Fluoxetine—Tachycardia—Doxorubicin—muscle cancer	0.000163	0.000437	CcSEcCtD
Fluoxetine—Skin disorder—Doxorubicin—muscle cancer	0.000162	0.000434	CcSEcCtD
Fluoxetine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000161	0.000432	CcSEcCtD
Fluoxetine—Anorexia—Doxorubicin—muscle cancer	0.000159	0.000426	CcSEcCtD
Fluoxetine—Feeling abnormal—Methotrexate—muscle cancer	0.000159	0.000426	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000157	0.000422	CcSEcCtD
Fluoxetine—Hypotension—Doxorubicin—muscle cancer	0.000156	0.000418	CcSEcCtD
Fluoxetine—Urticaria—Methotrexate—muscle cancer	0.000153	0.00041	CcSEcCtD
Fluoxetine—Abdominal pain—Methotrexate—muscle cancer	0.000152	0.000408	CcSEcCtD
Fluoxetine—Body temperature increased—Methotrexate—muscle cancer	0.000152	0.000408	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000152	0.000407	CcSEcCtD
Fluoxetine—Insomnia—Doxorubicin—muscle cancer	0.000151	0.000405	CcSEcCtD
Fluoxetine—Paraesthesia—Doxorubicin—muscle cancer	0.00015	0.000402	CcSEcCtD
Fluoxetine—Dyspnoea—Doxorubicin—muscle cancer	0.000149	0.000399	CcSEcCtD
Fluoxetine—Somnolence—Doxorubicin—muscle cancer	0.000148	0.000398	CcSEcCtD
Fluoxetine—Dyspepsia—Doxorubicin—muscle cancer	0.000147	0.000394	CcSEcCtD
Fluoxetine—Decreased appetite—Doxorubicin—muscle cancer	0.000145	0.000389	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000144	0.000386	CcSEcCtD
Fluoxetine—Fatigue—Doxorubicin—muscle cancer	0.000144	0.000386	CcSEcCtD
Fluoxetine—Pain—Doxorubicin—muscle cancer	0.000143	0.000382	CcSEcCtD
Fluoxetine—Constipation—Doxorubicin—muscle cancer	0.000143	0.000382	CcSEcCtD
Fluoxetine—Hypersensitivity—Methotrexate—muscle cancer	0.000142	0.000381	CcSEcCtD
Fluoxetine—Asthenia—Methotrexate—muscle cancer	0.000138	0.000371	CcSEcCtD
Fluoxetine—Feeling abnormal—Doxorubicin—muscle cancer	0.000137	0.000369	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000136	0.000366	CcSEcCtD
Fluoxetine—Pruritus—Methotrexate—muscle cancer	0.000136	0.000365	CcSEcCtD
Fluoxetine—Urticaria—Doxorubicin—muscle cancer	0.000132	0.000355	CcSEcCtD
Fluoxetine—Abdominal pain—Doxorubicin—muscle cancer	0.000132	0.000354	CcSEcCtD
Fluoxetine—Body temperature increased—Doxorubicin—muscle cancer	0.000132	0.000354	CcSEcCtD
Fluoxetine—Diarrhoea—Methotrexate—muscle cancer	0.000132	0.000353	CcSEcCtD
Fluoxetine—Dizziness—Methotrexate—muscle cancer	0.000127	0.000342	CcSEcCtD
Fluoxetine—Hypersensitivity—Doxorubicin—muscle cancer	0.000123	0.00033	CcSEcCtD
Fluoxetine—Vomiting—Methotrexate—muscle cancer	0.000122	0.000328	CcSEcCtD
Fluoxetine—Rash—Methotrexate—muscle cancer	0.000121	0.000326	CcSEcCtD
Fluoxetine—Dermatitis—Methotrexate—muscle cancer	0.000121	0.000325	CcSEcCtD
Fluoxetine—Headache—Methotrexate—muscle cancer	0.000121	0.000324	CcSEcCtD
Fluoxetine—Asthenia—Doxorubicin—muscle cancer	0.00012	0.000321	CcSEcCtD
Fluoxetine—Pruritus—Doxorubicin—muscle cancer	0.000118	0.000316	CcSEcCtD
Fluoxetine—Nausea—Methotrexate—muscle cancer	0.000114	0.000307	CcSEcCtD
Fluoxetine—Diarrhoea—Doxorubicin—muscle cancer	0.000114	0.000306	CcSEcCtD
Fluoxetine—Dizziness—Doxorubicin—muscle cancer	0.00011	0.000296	CcSEcCtD
Fluoxetine—Vomiting—Doxorubicin—muscle cancer	0.000106	0.000284	CcSEcCtD
Fluoxetine—Rash—Doxorubicin—muscle cancer	0.000105	0.000282	CcSEcCtD
Fluoxetine—Dermatitis—Doxorubicin—muscle cancer	0.000105	0.000282	CcSEcCtD
Fluoxetine—Headache—Doxorubicin—muscle cancer	0.000104	0.00028	CcSEcCtD
Fluoxetine—Nausea—Doxorubicin—muscle cancer	9.91e-05	0.000266	CcSEcCtD
